SCHEMBL13601533

SCHEMBL13601533

CCCOC(=O)C1CCN(C2CCN(C(=O)[C@H](C)Cc3cc(C)c4[nH]c(=O)oc4c3)CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
CALCRL Q16602 7/20 0.38
CYP3A4 P08684 3/20 0.38
ALDH1A1 P00352 4/20 0.37
GAA P10253 2/20 0.37
MEN1 O00255 2/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
KDM4E B2RXH2 1/20 0.34
PKM P14618 1/20 0.34
CALCA P06881 2/20 0.34
SMYD3 Q9H7B4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601534 0.95 KMT2A (0.38) KMT2ARAB9ANPC1CALCRLCYP3A4
SCHEMBL13601530 0.94 KMT2A (0.44) KMT2ARAB9ANPC1CALCRLCYP3A4
SCHEMBL13601535 0.94 KMT2A (0.37) KMT2ARAB9ANPC1CALCRLCYP3A4
SCHEMBL13601538 0.92 CALCRL (0.37) KMT2ARAB9ANPC1CALCRLCYP3A4
SCHEMBL13601541 0.91 CALCRL (0.36) KMT2ARAB9ANPC1CALCRLCYP3A4
SCHEMBL13601382 0.88 CALCRL (0.37) CALCRLCYP3A4CALCA
SCHEMBL13601494 0.86 CALCRL (0.38) CALCRLCYP3A4CALCA
SCHEMBL13601557 0.86 CALCRL (0.35) CALCRLCYP3A4ALDH1A1CALCASMYD3
SCHEMBL13601340 0.86 CALCRL (0.36) CALCRLCYP3A4CALCA
SCHEMBL13601574 0.86 CALCRL (0.35) CALCRLCYP3A4ALDH1A1CALCASMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed